Fatty Liver

MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
Jinho Jung, Rohan R Loomba, Kento Imajo, Egbert Madamba, Sanil Gandhi, Ricki Bettencourt, Seema Singh, Carolyn Hernandez, Mark A Valasek, Cynthia Behling, Lisa Richards, Katie Fowler, Claude B Sirlin, Atsushi Nakajima, Rohit Loomba

Gut Oct 2021, 70 (10) 1946-1953; DOI: 10.1136/gutjnl-2020-322976
IDDF2021-ABS-0203 A screening model for obstructive sleep apnea on the basis of fatty liver disease-related parameters
Yang-Bor Lu, Yu-Chieh Weng, Yung-Ning Huang, Hsiung-Ying Huang, Pei-Ting Cheng, Hui-Shan Hsieh, Ming-Shao Tsai

Gut Sep 2021, 70 (Suppl 2) A92; DOI: 10.1136/gutjnl-2021-IDDF.103
NAFLD between genes and environment: what drives fibrogenesis?
Angelo Armandi, Jörn M Schattenberg

Gut May 2021, 70 (5) 815-816; DOI: 10.1136/gutjnl-2020-321964
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Tracey G Simon, Bjorn Roelstraete, Hamed Khalili, Hannes Hagström, Jonas F Ludvigsson

Gut Jul 2021, 70 (7) 1375-1382; DOI: 10.1136/gutjnl-2020-322786
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function
Fabian Frost, Tim Kacprowski, Malte Rühlemann, Maik Pietzner, Corinna Bang, Andre Franke, Matthias Nauck, Uwe Völker, Henry Völzke, Marcus Dörr, Jan Baumbach, Matthias Sendler, Christian Schulz, Julia Mayerle, Frank U Weiss, Georg Homuth, Markus M Lerch

Gut Mar 2021, 70 (3) 522-530; DOI: 10.1136/gutjnl-2020-322753
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover
Yuki Tanaka, Yuta Shimanaka, Andrea Caddeo, Takuya Kubo, Yanli Mao, Tetsuya Kubota, Naoto Kubota, Toshimasa Yamauchi, Rosellina Margherita Mancina, Guido Baselli, Panu Luukkonen, Jussi Pihlajamäki, Hannele Yki-Järvinen, Luca Valenti, Hiroyuki Arai, Stefano Romeo, Nozomu Kono

Gut Jan 2021, 70 (1) 180-193; DOI: 10.1136/gutjnl-2020-320646
Microbial translocation in type 2 diabetes: when bacterial invaders overcome host defence in human obesity
Benjamin AH Jensen, Andre Marette

Gut Oct 2020, 69 (10) 1724-1726; DOI: 10.1136/gutjnl-2020-321288
S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development
Cyril Sobolewski, Daniel Abegg, Flavien Berthou, Dobrochna Dolicka, Nicolas Calo, Christine Sempoux, Margot Fournier, Christine Maeder, Anne-Sophie Ay, Pierre-Alain Clavien, Bostjan Humar, Jean-François Dufour, Alexander Adibekian, Michelangelo Foti

Gut Oct 2020, 69 (10) 1841-1854; DOI: 10.1136/gutjnl-2019-319019
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Silvia Sookoian, Adrian Salatino, Gustavo Osvaldo Castaño, Maria Silvia Landa, Cinthia Fijalkowky, Martin Garaycoechea, Carlos Jose Pirola

Gut Aug 2020, 69 (8) 1483-1491; DOI: 10.1136/gutjnl-2019-318811
Non-invasive diagnosis of patients with ‘at-risk’ NAFLD : only fibrosis counts?
Andreas Geier, Jerome Boursier

Gut Jul 2020, 69 (7) 1164-1165; DOI: 10.1136/gutjnl-2020-320785

Main menu

Fatty Liver

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Fatty Liver

Pages